Safety study of VV119 capsules in healthy Chinese volunteers
Treatments studied
Part of Mental health clinical trials.
This trial tests the safety of a new medication, VV119, in healthy Chinese volunteers. It looks at how the body processes the drug and whether food affects it. Healthy adults who meet the study's requirements can participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult, aged 18 to 60 (specific age limits vary by gender).
- Your body weight is at least 45 kg (if female) or 50 kg (if male), with a Body Mass Index (BMI) between 19 and 26.
- You are willing to use effective birth control during the study and for 3 months after (if male), or you are not capable of becoming pregnant (if female).
- You have no significant current or past medical conditions that could affect the trial, such as heart, liver, kidney, or mental health disorders.
- You have not taken any prescription or over-the-counter medications, including herbal supplements, within 2 weeks before screening, and have not used certain drugs that affect liver enzymes within 4 weeks.
- You do not smoke more than 5 cigarettes a day, drink excessive alcohol, or use recreational drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new drug called VV119 is safe and how it works in the body. It is for healthy volunteers and for people who have had schizophrenia for at least a year and are currently having worsening symptoms.
This trial tests a new medication called VV119 for adults currently experiencing a sudden worsening of schizophrenia symptoms. The goal is to see if it is safe and if it helps reduce symptoms like delusions, disorganized thinking, and hallucinations.
This is an early-stage study testing a new experimental drug called KR23248 in healthy volunteers to see if it is safe and how the body processes it. Researchers want to understand potential side effects and how the drug moves through your system.
This study tests a new capsule called VV913 in healthy male volunteers to see how safe it is and how the body processes it. It is a first-in-human trial in China to gather basic safety information.
This early-phase trial tests VV913 capsules in healthy men to see how safe they are and how the body processes the drug. It may help find the right dose for future studies.
This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.